Literature DB >> 16695263

STUDIES IN BLOOD COAGULATION: THE COAGULATION PROPERTIES OF CERTAIN GLOBULIN FRACTIONS OF NORMAL HUMAN PLASMA IN VITRO.

F H Taylor1, C S Davidson, H J Tagnon, M A Adams, A H Macdonald, G R Minot.   

Abstract

Entities:  

Year:  1945        PMID： 16695263      PMCID： PMC435505          DOI： 10.1172/JCI101653

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  8 in total

1.  HEMOPHILIA. II. SOME PROPERTIES OF A SUBSTANCE OBTAINED FROM NORMAL HUMAN PLASMA EFFECTIVE IN ACCELERATING THE COAGULATION OF HEMOPHILIC BLOOD.

Authors:  A J Patek; F H Taylor
Journal:  J Clin Invest       Date:  1937-01       Impact factor: 14.808

2.  CHEMICAL, CLINICAL, AND IMMUNOLOGICAL STUDIES ON THE PRODUCTS OF HUMAN PLASMA FRACTIONATION. I. THE CHARACTERIZATION OF THE PROTEIN FRACTIONS OF HUMAN PLASMA.

Authors:  E J Cohn; J L Oncley; L E Strong; W L Hughes; S H Armstrong
Journal:  J Clin Invest       Date:  1944-07       Impact factor: 14.808

3.  STUDIES ON BLOOD COAGULATION: A PROTEOLYTIC ENZYME PREPARED FROM CALCIUM AND PLATELET FREE NORMAL HUMAN BLOOD PLASMA.

Authors:  H J Tagnon; C S Davidson; F H Taylor
Journal:  J Clin Invest       Date:  1942-09       Impact factor: 14.808

4.  PRESERVATION OF NORMAL HUMAN PLASMA IN THE LIQUID STATE. II. COMPARATIVE IN VITRO STUDIES ON THE PHYSIOLOGIC ACTIVITY OF LABILE CONSTITUENTS OF LIQUID AND FROZEN PLASMA.

Authors:  F H Taylor; E L Lozner; C S Davidson; H J Tagnon; L R Newhouser; H Macdonald; M A Adams
Journal:  J Clin Invest       Date:  1944-05       Impact factor: 14.808

5.  STUDIES ON BLOOD COAGULATION: THE NATURE AND PROPERTIES OF A PROTEOLYTIC ENZYME DERIVED FROM PLASMA.

Authors:  M H Kaplan; H J Tagnon; C S Davidson; F H Taylor
Journal:  J Clin Invest       Date:  1942-09       Impact factor: 14.808

6.  CHEMICAL, CLINICAL, AND IMMUNOLOGICAL STUDIES ON THE PRODUCTS OF HUMAN PLASMA FRACTIONATION. XV. THE PROTEINS CONCERNED IN THE BLOOD COAGULATION MECHANISM.

Authors:  J T Edsall; R M Ferry; S H Armstrong
Journal:  J Clin Invest       Date:  1944-07       Impact factor: 14.808

7.  THE COAGULATION DEFECT IN HEMOPHILIA: STUDIES OF THE CLOT PROMOTING ACTIVITY ASSOCIATED WITH PLASMA EUGLOBULIN IN HEMOPHILIA.

Authors:  E L Lozner; F H Taylor
Journal:  J Clin Invest       Date:  1939-11       Impact factor: 14.808

8.  THE COAGULATION DEFECT IN HEMOPHILIA: THE CLOT PROMOTING ACTIVITY IN HEMOPHILIA OF BERKEFELDED NORMAL HUMAN PLASMA FREE FROM FIBRINOGEN AND PROTHROMBIN.

Authors:  E L Lozner; R Kark; F H Taylor
Journal:  J Clin Invest       Date:  1939-09       Impact factor: 14.808
  8 in total
  10 in total

1.  EFFECT OF BLOOD PROTEASE AND TRYPSIN INHIBITOR ON THE CLOTTING MECHANISM.

Authors:  A J Glazko
Journal:  J Clin Invest       Date:  1947-05       Impact factor: 14.808

2.  THE COAGULATION DEFECT IN HEMOPHILIA: THE EFFECT, IN HEMOPHILIA, OF THE PARENTERAL ADMINISTRATION OF A FRACTION OF THE PLASMA GLOBULINS RICH IN FIBRINOGEN.

Authors:  G R Minot; C S Davidson; J H Lewis; H J Tagnon; F H Taylor
Journal:  J Clin Invest       Date:  1945-09       Impact factor: 14.808

3.  STUDIES OF HEMOPHILIA. II. THE ASSAY OF THE ANTIHEMOPHILIC CLOT-PROMOTING PRINCIPLE IN NORMAL HUMAN PLASMA WITH SOME OBSERVATIONS ON THE RELATIVE POTENCY OF CERTAIN PLASMA FRACTIONS.

Authors:  B Alexander; G Landwehr
Journal:  J Clin Invest       Date:  1948-01       Impact factor: 14.808

4.  CHEMICAL, CLINICAL AND IMMUNOLOGICAL STUDIES ON THE PRODUCTS OF HUMAN PLASMA FRACTIONATION: XXXII. THE COAGULATION DEFECT IN HEMOPHILIA. AN IN VITRO AND IN VIVO COMPARISON OF NORMAL AND HEMOPHILIC WHOLE BLOOD, PLASMA AND DERIVED PLASMA PROTEIN FRACTIONS.

Authors:  J H Lewis; C S Davidson; G R Minot; J P Soulier; H J Tagnon; F H Taylor
Journal:  J Clin Invest       Date:  1946-11       Impact factor: 14.808

5.  Clinical implications of plasma fractionation.

Authors:  I H SCHEINBERG
Journal:  Bull N Y Acad Med       Date:  1954-10

6.  Chemical, physiological, and immunological properties and clinical uses of blood derivatives.

Authors:  E J COHN
Journal:  Experientia       Date:  1947-04-15

7.  [Hemophilia, deficiency condition or excess of antibodies?].

Authors:  E Hecht
Journal:  Klin Wochenschr       Date:  1966-07-15

8.  CHEMICAL, CLINICAL AND IMMUNOLOGICAL STUDIES ON THE PRODUCTS OF HUMAN PLASMA FRACTIONATION. XXXIII. THE COAGULATION DEFECT IN HEMOPHILIA: THE EFFECT IN VITRO AND IN VIVO ON THE COAGULATION TIME IN HEMOPHILIA OF A PROTHROMBIN AND FIBRINOGEN-FREE NORMAL PLASMA AND ITS DERIVED PROTEIN FRACTIONS.

Authors:  J H Lewis; J P Soulier; F H Taylor
Journal:  J Clin Invest       Date:  1946-11       Impact factor: 14.808

9.  Studies on a proteolytic enzyme in human plasma; the relationship between the proteolytic activity of plasma and blood coagulation.

Authors:  O D RATNOFF; R C HARTMANN; C L CONLEY
Journal:  J Exp Med       Date:  1950-02       Impact factor: 14.307

10.  Proteolytic enzymes; further studies on protein, polypeptide, and other inhibitors of serum proteinase, leucoproteinase, trypsin, and papain.

Authors:  D GROB
Journal:  J Gen Physiol       Date:  1949-11       Impact factor: 4.086
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.